We are thrilled to present to our community the launch of the product VETRANO® palbociclib, for our Oncology Line. VETRANO® palbociclib is indicated for the treatment of hormone receptor positive (HR+) and human epidermal growth factor receptor 2 (HER2-) negative, metastatic or locally advanced breast cancer. VETRANO® palbociclib is available in the following dosages: 75 mg...
Bioprofarma Bagó is pleased to present the launch of the product TSUMIS® carfilzomib, for its Hematology Line. TSUMIS® carfilzomib is approved by ANMAT, in combination with daratumumab and dexamethasone, lenalidomide and dexamethasone or dexamethasone alone, for the treatment of adult patients with multiple myeloma who have received at least one prior treatment. TSUMIS® carfilzomib is...
At Bioprofarma Bagó, we are excited to present the launch of the product DALCARA® sorafenib, for our Oncology Business Unit. DALCARA® sorafenib is approved by ANMAT for:- the treatment of liver cancer (hepatocellular carcinoma);- the treatment of advanced stage renal cancer (advanced renal cell carcinoma) when standard treatment has not helped to stop the...
Bioprofarma Bagó is proud to present the launch of GOMBRICH® cabazitaxel, for its Oncology Business Unit. GOMBRICH® cabazitaxel is used for the treatment of prostate cancer that has progressed after having received other chemotherapy. It works by stopping cell growth and multiplication. GOMBRICH® cabazitaxel is available as a concentrated solution for infusion in a single...
Bioprofarma Bagó is pleased to present the launch of BIOPONIB® ponatinib for its Hematology Business Unit. BIOPONIB® ponatinib is approved by ANMAT for the treatment of Chronic Myeloid Leukemia (CML) and Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ ALL) in adult patients who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or...
ANTIXAN® edaravone is approved by ANMAT for the following indications: Inhibition in the progression of functional disorders in patients with Amyotrophic Lateral Seclerosis (ALS) Improve neurological symptoms, disorders in daily activities. PRESENTATION: 30 mg x 10 injection
Bioprofarma Bagó presents CarciVac® for the treatment of non-muscle invasive bladder cancer. We are pleased to announce the launch of CarciVac® vaccine onco BCG Bacilo Calmette-Guérin. This product complements our Urology portfolio continuing our commitment to patients suffering bladder cancer. CarciVac® is manufactured by Serum Institute of India, the world's largest producer of vaccines, which allows us...
